参考文献/References:
[1] Joshi J J,Coffey H,Corcoran E,et al.H3B-6527 is a potent and selective inhibitor of FGFR4 in FGF19-driven hepatocellular[J].Carcinoma Cancer Res,2017,77(24):6999-7013.
[2] Raja A,Park I,Haq F,et al.FGF19-FGFR4 signaling in hepatocellular carcinoma[J].Cells,2019,8(6):536-552.
[3] Sandberg T P, Stuart MPME, Osting J,et al.Increased expression of caner-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer[J].BMC Cancer,2019,19(1):284-314.
[4] Deying W,Feng G,Shumei L,et al.CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-met/PI3K/Akt and GRP78 signalling inovarian cancer cells[J]. Biosci Rep,2017,37(2):1-12.
[5] Zhao H K.FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3β/β-catenin signaling cascade via FGFR4 activation[J].Oncotarget,2016,7(12),13575-13586.
[6] Kan Z, Zheng H, Liu X, et al.Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma [J]. Genome Res,2013,23(9):1422-1433.
[7] Zhao H, Lv F, Liang G,et al.FGF19 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells by modulating the GSK3beta/beta-catenin signaling cascade via FGFR4 activation[J]. Oncotarget,2016(7):13575-13586.